Activation of TRPV1 by capsaicin induces functional Kinin B1 receptor in rat spinal cord microglia

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Talbot, Sébastien ^a   Dias, Jenny P ^a   Lahjouji, Karim ^a   Bogo, Maurício R ^b,c   Campos, Maria M ^b   Gaudreau, Pierrette ^d   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c National Institute for Translational Medicine INCT TM   (Brazil)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

B1 receptors; Bradykinin; Capsaicin; Oxidative stress; Thermal hyperalgesia; TRPV1

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; ACETYLCYSTEINE; BRADYKININ B1 RECEPTOR; CAPSAICIN; CAPSAZEPINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SUBSTANCE P; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ANILIDE; ANTIOXIDANT; BRADYKININ; BRADYKININ, HYP(3) THI(5) TIC(7) OIC(8) DESARG(9); BRADYKININ, HYP(3)-THI(5)-TIC(7)-OIC(8)-DESARG(9)-; CINNAMIC ACID DERIVATIVE; DRUG DERIVATIVE; IODINE; N (3 METHOXYPHENYL) 4 CHLOROCINNAMANILIDE; N-(3-METHOXYPHENYL)-4-CHLOROCINNAMANILIDE; TETRAHYDROISOQUINOLINE DERIVATIVE; VANILLOID RECEPTOR; VANILLOID RECEPTOR SUBTYPE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRADYKININ B1 RECEPTOR GENE; CELLULAR DISTRIBUTION; CERVICAL SPINAL CORD; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE; GENE EXPRESSION REGULATION; HYPERALGESIA; INTERLEUKIN 1BETA GENE; LUMBAR SPINAL CORD; MALE; MICROGLIA; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; THORACIC SPINAL CORD; TUMOR NECROSIS FACTOR ALPHA GENE; ANALYSIS OF VARIANCE; ANIMAL; AUTORADIOGRAPHY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PROTEIN BINDING; SPINAL CORD; SPRAGUE DAWLEY RAT; TIME;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANILIDES; ANIMALS; ANTIOXIDANTS; AUTORADIOGRAPHY; BRADYKININ; CAPSAICIN; CINNAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; IODINE ISOTOPES; MALE; MICROGLIA; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1; RNA, MESSENGER; SENSORY SYSTEM AGENTS; SPINAL CORD; SUPEROXIDES; TETRAHYDROISOQUINOLINES; TIME FACTORS; TRPV CATION CHANNELS;

EID: 84855998903     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-16     Document Type: Article

References (69)

1. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001, 429:161-176. 10.1016/S0014-2999(01)01318-8, 11698039.
2. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 2004, 143:803-818. 10.1038/sj.bjp.0706012, 1575942, 15520046.
3. Petcu M, Dias JP, Ongali B, Thibault G, Neugebauer W, Couture R. Role of kinin B1 and B2 receptors in a rat model of neuropathic pain. Int Immunopharmacol 2008, 8:188-196. 10.1016/j.intimp.2007.09.009, 18182225.
4. Dias JP, Talbot S, Senecal J, Carayon P, Couture R. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications. PLoS One 2010, 5:e12622. 10.1371/journal.pone.0012622, 2935380, 20830306.
5. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980, 32:1-46.
6. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005, 57:27-77. 10.1124/pr.57.1.2, 15734727.
7. Marceau F, Bachvarov DR. Kinin receptors. Clin Rev Allergy Immunol 1998, 16:385-401. 10.1007/BF02737658, 9926287.
8. Ismael MA, Talbot S, Carbonneau CL, Beausejour CM, Couture R. Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Eur J Pharmacol 2008, 589:66-72. 10.1016/j.ejphar.2008.05.006, 18555989.
9. Couture R, Girolami JP. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur J Pharmacol 2004, 500:467-485. 10.1016/j.ejphar.2004.07.045, 15464053.
10. deBlois D, Horlick RA. Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects. Br J Pharmacol 2001, 132:327-335. 10.1038/sj.bjp.0703748, 1572522, 11156593.
11. Bachvarov DR, Hess JF, Menke JG, Larrivee JF, Marceau F. Structure and genomic organization of the human B1 receptor gene for kinins (BDKRB1). Genomics 1996, 33:374-381. 10.1006/geno.1996.0213, 8660997.
12. Gabra BH, Sirois P. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor. Eur J Pharmacol 2005, 514:61-67. 10.1016/j.ejphar.2005.03.018, 15878325.
13. Gabra BH, Merino VF, Bader M, Pesquero JB, Sirois P. Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice. Regul Pept 2005, 127:245-248. 10.1016/j.regpep.2004.12.003, 15680494.
14. Gabra BH, Sirois P. Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice. Inflamm Res 2004, 53:653-657. 10.1007/s00011-004-1310-0, 15654512.
15. Lungu C, Dias JP, Franca CE, Ongali B, Regoli D, Moldovan F, Couture R. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance. Neuropeptides 2007, 41:375-387. 10.1016/j.npep.2007.09.005, 17988733.
16. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007, 6:357-372. 10.1038/nrd2280, 17464295.
17. Kim SR, Kim SU, Oh U, Jin BK. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release. J Immunol 2006, 177:4322-4329.
18. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313. 10.1126/science.288.5464.306, 10764638.
19. Moriyama T, Iida T, Kobayashi K, Higashi T, Fukuoka T, Tsumura H, Leon C, Suzuki N, Inoue K, Gachet C, et al. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 2003, 23:6058-6062.
20. Szabo A, Helyes Z, Sandor K, Bite A, Pinter E, Nemeth J, Banvolgyi A, Bolcskei K, Elekes K, Szolcsanyi J. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. J Pharmacol Exp Ther 2005, 314:111-119. 10.1124/jpet.104.082487, 15831443.
21. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000, 408:985-990. 10.1038/35050121, 11140687.
22. Numazaki M, Tominaga T, Toyooka H, Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 2002, 277:13375-13378. 10.1074/jbc.C200104200, 11884385.
23. Jordt SE, Tominaga M, Julius D. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 2000, 97:8134-8139. 10.1073/pnas.100129497, 16682, 10859346.
24. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001, 411:957-962. 10.1038/35082088, 11418861.
25. Chuang HH, Lin S. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc Natl Acad Sci USA 2009, 106:20097-20102. 2785298, 19897733.
26. Ma F, Zhang L, Westlund KN. Reactive oxygen species mediate TNFR1 increase after TRPV1 activation in mouse DRG neurons. Mol Pain 2009, 5:31. 10.1186/1744-8069-5-31, 2706230, 19531269.
27. Hu F, Sun WW, Zhao XT, Cui ZJ, Yang WX. TRPV1 mediates cell death in rat synovial fibroblasts through calcium entry-dependent ROS production and mitochondrial depolarization. Biochem Biophys Res Commun 2008, 369:989-993. 10.1016/j.bbrc.2008.02.155, 18331834.
28. Schilling T, Eder C. Importance of the non-selective cation channel TRPV1 for microglial reactive oxygen species generation. J Neuroimmunol 2009, 216:118-121. 10.1016/j.jneuroim.2009.07.008, 19683814.
29. Talbot S, Theberge-Turmel P, Liazoghli D, Senecal J, Gaudreau P, Couture R. Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin. J Neuroinflammation 2009, 6:11. 10.1186/1742-2094-6-11, 2667487, 19323833.
30. Talbot S, Chahmi E, Dias JP, Couture R. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy. J Neuroinflammation 2010, 7:36. 10.1186/1742-2094-7-36, 2913947, 20587056.
31. Couture R, Escher E, Regoli D. Effects of substance P analogues in the rat tail-flick test. Eur J Pharmacol 1987, 134:355-359. 10.1016/0014-2999(87)90369-4, 2436927.
32. Oliverio A, Castellano C, Puglisi-Allegra S. Opiate analgesia: evidence for circadian rhythms in mice. Brain Res 1982, 249:265-270. 10.1016/0006-8993(82)90060-9, 7139304.
33. Ferreira J, Campos MM, Araujo R, Bader M, Pesquero JB, Calixto JB. The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level. Neuropharmacology 2002, 43:1188-1197. 10.1016/S0028-3908(02)00311-8, 12504926.
34. Yashpal K, Henry JL. Endorphins mediate overshoot of substance P-induced facilitation of a spinal nociceptive reflex. Can J Physiol Pharmacol 1983, 61:303-307. 10.1139/y83-046, 6190542.
35. Furfine ES, Harmon MF, Paith JE, Garvey EP. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry 1993, 32:8512-8517. 10.1021/bi00084a017, 7689333.
36. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, Laduron PM. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 1991, 88:10208-10212. 10.1073/pnas.88.22.10208, 52897, 1719549.
37. Kent S, Kernahan SD, Levine S. Effects of excitatory amino acids on the hypothalamic-pituitary-adrenal axis of the neonatal rat. Brain Res Dev Brain Res 1996, 94:1-13.
38. Gougat J, Ferrari B, Sarran L, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, et al. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl ]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]pheny l)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 2004, 309:661-669. 10.1124/jpet.103.059527, 14747609.
39. Dias JP, Ismael MA, Pilon M, de Champlain J, Ferrari B, Carayon P, Couture R. The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance. Br J Pharmacol 2007, 152:280-287. 10.1038/sj.bjp.0707388, 1978253, 17618300.
40. Gauchan P, Andoh T, Kato A, Kuraishi Y. Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci Lett 2009, 458:93-95. 10.1016/j.neulet.2009.04.029, 19375484.
41. Horvath G, Kekesi G, Nagy E, Benedek G. The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. Pain 2008, 134:277-284. 10.1016/j.pain.2007.04.032, 17533116.
42. Varga A, Nemeth J, Szabo A, McDougall JJ, Zhang C, Elekes K, Pinter E, Szolcsanyi J, Helyes Z. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett 2005, 385:137-142. 10.1016/j.neulet.2005.05.015, 15950380.
43. Niiyama Y, Kawamata T, Yamamoto J, Furuse S, Namiki A. SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Br J Anaesth 2009, 102:251-258. 10.1093/bja/aen347, 19038965.
44. Chen Y, Geis C, Sommer C. Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci 2008, 28:5836-5845. 10.1523/JNEUROSCI.4170-07.2008, 18509045.
45. Regoli D, Nsa Allogho S, Rizzi A, Gobeil FJ. Bradykinin receptors and their antagonists. Eur J Pharmacol 1998, 348:1-10. 10.1016/S0014-2999(98)00165-4, 9650825.
46. Nazarali AJ, Gutkind JS, Saavedra JM. Calibration of 125I-polymer standards with 125I-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Methods 1989, 30:247-253. 10.1016/0165-0270(89)90135-0, 2607785.
47. Gendron ME, Theoret JF, Mamarbachi AM, Drouin A, Nguyen A, Bolduc V, Thorin-Trescases N, Merhi Y, Thorin E. Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis. Am J Physiol Heart Circ Physiol 2010, 298:H2062-2070. 10.1152/ajpheart.00532.2009, 20382853.
48. Lin JC, Talbot S, Lahjouji K, Roy JP, Senecal J, Couture R, Morin A. Mechanism of cigarette smoke-induced kinin B(1) receptor expression in rat airways. Peptides 2010, 31:1940-1945. 10.1016/j.peptides.2010.07.008, 20637817.
49. Talbot S, Couture R. Emerging role of microglial kinin B1 receptor in diabetic pain neuropathy. Experimental Neurology 2011,
50. Papoiu AD, Yosipovitch G. Topical capsaicin. The fire of a 'hot' medicine is reignited. Expert Opin Pharmacother 2010, 11:1359-1371. 10.1517/14656566.2010.481670, 20446852.
51. Meddings JB, Hogaboam CM, Tran K, Reynolds JD, Wallace JL. Capsaicin effects on non-neuronal plasma membranes. Biochim Biophys Acta 1991, 1070:43-50. 10.1016/0005-2736(91)90144-W, 1751537.
52. Hogaboam CM, Wallace JL. Inhibition of platelet aggregation by capsaicin. An effect unrelated to actions on sensory afferent neurons. Eur J Pharmacol 1991, 202:129-131. 10.1016/0014-2999(91)90267-T, 1786800.
53. Ritter S, Dinh TT. Capsaicin-induced neuronal degeneration in the brain and retina of preweanling rats. J Comp Neurol 1990, 296:447-461. 10.1002/cne.902960310, 2358547.
54. Docherty RJ, Yeats JC, Piper AS. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br J Pharmacol 1997, 121:1461-1467. 10.1038/sj.bjp.0701272, 1564831, 9257928.
55. Andrade EL, Luiz AP, Ferreira J, Calixto JB. Pronociceptive response elicited by TRPA1 receptor activation in mice. Neuroscience 2008, 152:511-520. 10.1016/j.neuroscience.2007.12.039, 18272293.
56. Wu C, Gavva NR, Brennan TJ. Effect of AMG0347, a transient receptor potential type V1 receptor antagonist, and morphine on pain behavior after plantar incision. Anesthesiology 2008, 108:1100-1108. 10.1097/ALN.0b013e31817302b3, 18497612.
57. Talbot S, Lin JC, Lahjouji K, Roy JP, Senecal J, Morin A, Couture R. Cigarette smoke-induced kinin B1 receptor promotes NADPH oxidase activity in cultured human alveolar epithelial cells. Peptides 2011, 32:1447-56. 10.1016/j.peptides.2011.05.005, 21600945.
58. Petcu M, Ongali B, El Midaoui A, de Champlain J, Couture R. Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats. Peptides 2005, 26:1331-1338. 10.1016/j.peptides.2005.03.047, 15878793.
59. Westlund KN, Kochukov MY, Lu Y, McNearney TA. Impact of central and peripheral TRPV1 and ROS levels on proinflammatory mediators and nociceptive behavior. Mol Pain 2010, 6:46. 10.1186/1744-8069-6-46, 2924298, 20691059.
60. Reilly CA, Johansen ME, Lanza DL, Lee J, Lim JO, Yost GS. Calcium-dependent and independent mechanisms of capsaicin receptor (TRPV1)-mediated cytokine production and cell death in human bronchial epithelial cells. J Biochem Mol Toxicol 2005, 19:266-275. 10.1002/jbt.20084, 2291358, 16173059.
61. Bodo E, Biro T, Telek A, Czifra G, Griger Z, Toth BI, Mescalchin A, Ito T, Bettermann A, Kovacs L, Paus R. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005, 166:985-998. 10.1016/S0002-9440(10)62320-6, 1602392, 15793280.
62. Takano F, Yamaguchi M, Takada S, Shoda S, Yahagi N, Takahashi T, Ohta T. Capsicum ethanol extracts and capsaicin enhance interleukin-2 and interferon-gamma production in cultured murine Peyer's patch cells ex vivo. Life Sci 2007, 80:1553-1563. 10.1016/j.lfs.2007.01.031, 17306834.
63. Sappington RM, Calkins DJ. Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure. Invest Ophthalmol Vis Sci 2008, 49:3004-3017. 10.1167/iovs.07-1355, 18362111.
64. Ni A, Chai KX, Chao L, Chao J. Molecular cloning and expression of rat bradykinin B1 receptor. Biochim Biophys Acta 1998, 1442:177-185.
65. Campos MM, Souza GE, Calixto JB. In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways. Br J Pharmacol 1999, 127:1851-1859. 10.1038/sj.bjp.0702715, 1566166, 10482916.
66. Radhakrishnan V, Yashpal K, Hui-Chan CW, Henry JL. Implication of a nitric oxide synthase mechanism in the action of substance P: L-NAME blocks thermal hyperalgesia induced by endogenous and exogenous substance P in the rat. Eur J Neurosci 1995, 7:1920-1925. 10.1111/j.1460-9568.1995.tb00714.x, 8528467.
67. Radhakrishnan V, Henry JL. L-NAME blocks responses to NMDA, substance P and noxious cutaneous stimuli in cat dorsal horn. Neuroreport 1993, 4:323-326. 10.1097/00001756-199303000-00025, 7682858.
68. Yashpal K, Radhakrishnan V, Henry JL. NMDA receptor antagonist blocks the facilitation of the tail flick reflex in the rat induced by intrathecal administration of substance P and by noxious cutaneous stimulation. Neurosci Lett 1991, 128:269-272. 10.1016/0304-3940(91)90277-Z, 1719454.
69. Raigorodsky G, Urca G. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res 1987, 422:158-162. 10.1016/0006-8993(87)90551-8, 2890415.